Inactive Instrument
CannaVEST Corp Share Price OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 02/06 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 15/05 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 41.76L 36.59L 33.97L 31.21L 58.81L 40Cr 59.68L 4.05Cr 1.58Cr 20Cr 1.57Cr 1.53Cr 68Cr | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 58.94L 51.64L 47.94L 44.05L 83.01L 57Cr 84.23L 5.71Cr 2.24Cr 28Cr 2.21Cr 2.16Cr 96Cr | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.05% | +0.55% | +49.79% | +151.71% | 1,03700Cr | ||
| +2.00% | +3.49% | +52.22% | +50.20% | 62TCr | ||
| -1.09% | +3.76% | +35.37% | +76.22% | 45TCr | ||
| +3.04% | +2.83% | +30.50% | +24.68% | 33TCr | ||
| -0.19% | +1.25% | +34.02% | +37.44% | 29TCr | ||
| -0.58% | -0.10% | +18.19% | +17.03% | 26TCr | ||
| -2.25% | -7.49% | -29.84% | -43.52% | 22TCr | ||
| -0.05% | +2.16% | +19.75% | +55.89% | 20TCr | ||
| +0.05% | -1.03% | +18.31% | +61.63% | 16TCr | ||
| Average | -0.25% | +1.12% | +25.37% | +47.92% | 39.53TCr | |
| Weighted average by Cap. | -0.36% | +1.47% | +35.06% | +72.37% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.57Cr 1.38Cr 1.28Cr 1.17Cr 2.21Cr 151.55Cr 2.24Cr 15Cr 5.96Cr 74Cr 5.9Cr 5.77Cr 256.16Cr | 1.38Cr 1.21Cr 1.12Cr 1.03Cr 1.94Cr 133.06Cr 1.97Cr 13Cr 5.23Cr 65Cr 5.18Cr 5.06Cr 224.91Cr |
| Net income | -23.94L -20.98L -19.47L -17.89L -33.72L -23Cr -34.22L -2.32Cr -90.8L -11Cr -89.87L -87.93L -39Cr | -10L -8L -8L -7L -13.49L -9.24Cr -13.69L -92.83L -36.33L -4.52Cr -35.96L -35.19L -16Cr |
| Net Debt | 3L 3L 3L 2L 5L 3.14Cr 5L 31.49L 12.33L 1.53Cr 12.2L 11.94L 5.3Cr | 17.18L 15.05L 13.97L 12.84L 24.2L 17Cr 24.55L 1.66Cr 65.16L 8.11Cr 64.49L 63.1L 28Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















